Circulating Insulin-Like Growth Factor-1 Level and Ovarian Cancer Risk | Zendy

Yiyang Li | Zendy; Yang Li | Zendy; Jialing Zhang | Zendy; Changjun Zheng | Zendy; He Zhu | Zendy; Huimei Yu | Zendy; Limei Fan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Circulating Insulin-Like Growth Factor-1 Level and Ovarian Cancer Risk

Author(s) -

Yiyang Li,

Yang Li,

Jialing Zhang,

Changjun Zheng,

He Zhu,

Huimei Yu,

Limei Fan

Publication year - 2016

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000438652

Subject(s) - ovarian cancer , medicine , odds ratio , meta analysis , oncology , confidence interval , risk factor , cancer , case control study , insulin like growth factor , subgroup analysis , endocrinology , gynecology , growth factor , receptor

Insulin-like growth factor-1 (IGF-1) has an important role in cells' proliferation, differentiation and apoptosis, and it may be involved in carcinogenesis. Several epidemiological studies assessed the association between circulating IGF-1 level and ovarian cancer risk, but there was still no conclusive finding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research